tldrdaily.news logo
Tag

Alpelisib

All articles tagged with #alpelisib

health2 years ago

"Alarming Discovery: Common Cancer Drug Linked to Serious Side Effect, Scientists Warn"

Recent research has found that breast cancer patients treated with the drug alpelisib are experiencing a high occurrence of hyperglycemia, or high blood sugar. The study emphasizes the importance of early detection and management of high blood sugar levels to improve cancer treatment effectiveness and reduce the risk of severe side effects. Alpelisib, which inhibits the phosphoinositide 3-kinase (PI3K) protein, can lead to hyperglycemia as a side effect, potentially resulting in dehydration or kidney damage. The study highlights the need for proactive monitoring and treatment of blood sugar levels in patients receiving alpelisib to optimize their cancer treatment outcomes.

via SciTechDaily|
#alpelisib#breast-cancer#cancer
health2 years ago

"New Research Uncovers Potentially Serious Side Effect of Breast Cancer Drug"

A study from the Memorial Sloan Kettering Cancer Center has found that the breast cancer drug alpelisib can cause elevated blood sugar rates, or hyperglycemia, in some patients. Among 147 patients treated with alpelisib, the rate of hyperglycemia was 80.3%, with 40.2% experiencing serious hyperglycemia. The condition typically began 16 days after starting the medication, and patients with pre-existing diabetes or pre-diabetes were at a higher risk. While hyperglycemia can have serious complications, such as dehydration and kidney damage, the side effects can usually be managed with medication and lifestyle changes. Oncologists are advised to monitor blood sugar levels and optimize patients' metabolic health before starting alpelisib treatment.

via New York Post |
#alpelisib#breast-cancer#cancer-treatment
health2 years ago

"New Research Uncovers Potentially Serious Side Effect of Breast Cancer Drug"

A study from the Memorial Sloan Kettering Cancer Center has found that the breast cancer drug alpelisib can cause elevated blood sugar rates, or hyperglycemia, in some patients. Among 147 patients treated with alpelisib, the rate of hyperglycemia was 80.3%, with 40.2% experiencing serious hyperglycemia. The condition typically began 16 days after starting the medication, and patients with pre-existing diabetes or pre-diabetes were at a higher risk. While hyperglycemia is a known side effect, doctors believe it can be managed through monitoring and lifestyle changes. Alternative treatment options are available for patients who experience this side effect.

via Fox News|
#alpelisib#breast-cancer-drug#cancer-treatment
health2 years ago

N-acetylcysteine: A Promising Supplement for Fighting Breast Cancer

Researchers at the University of Basel have discovered that the loss of the NF1 protein is responsible for resistance to the breast cancer drug alpelisib. They found that the antioxidant N-acetylcysteine, a common dietary supplement, restored and even enhanced the effectiveness of alpelisib in resistant cancer cells. The next step is to conduct clinical studies with breast cancer patients to confirm the positive effects observed in the laboratory.

via Earth.com|
#alpelisib#breast-cancer#cancer-treatment